Sachin Nashik Sanap

Sachin Nashik Sanap

Auto-generated profile, based on publicly available information

Sachin Nashik Sanap

Pharmaceutics & Pharmacokinetics Division CSIR‐Central Drug Research Institute Lucknow Uttar Pradesh India

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 April 2024 in Medcomm – Biomaterials and Applications
Verified
Journal Article
Open access
ABAmol C. Bisen
Amol C. Bisen
ABArpon Biswas
Arpon Biswas
ADAyush Dubey
Ayush Dubey
SSSachin N. Sanap
Sachin N. Sanap
SASristi Agrawal
Sristi Agrawal
RBRabi S. Bhatta
Rabi S. Bhatta
Amid the escalating prevalence of eye diseases and the intricate nature of the eye as a crucial target organ for drug delivery, researchers face significant challenges in developing delivery systems tailored specifically for ocular complications. Addressing the gaps in the current conventional ocular drug delivery system (ODDS) is crucial and this can be achieved by incorporating polymers while designing newer ODDS. This review aims to offer a concise overview of the diverse polymers utilized in the development of ODDS, designed to address various eye conditions and disorders, enhance treatment outcomes, and ensure patient adherence. Introducing the anatomy of the eye and different ocular routes of administration, alongside the barriers encountered, this review presents polymer‐based ODDS, renowned for their unique properties facilitating the engineering of specialized devices for enhanced drug delivery. Further discussions delve into the applications of polymers in ophthalmology. Emphasis is placed on emerging polymer‐based technologies available in the market for treating ocular diseases, underscoring their potential for revolutionizing ocular healthcare. The review also addresses challenges in translating these advancements into clinical practice, while highlighting the versatility of polymers in treating diverse eye diseases and disorders through customizable properties and sustained drug delivery.

31 July 2023 in Molecular Pharmaceutics
Verified
Journal Article
Closed access
MHMayank Handa
Mayank Handa
SSSachin Nashik Sanap
Sachin Nashik Sanap
RBRabi Sankar Bhatta
Rabi Sankar Bhatta
GPGajanan Pratap Patil
Gajanan Pratap Patil
RPRAJENDRA PALKHADE
RAJENDRA PALKHADE
RSRahul Shukla
Rahul Shukla

27 February 2023 in Biomedical Chromatography
Verified
Journal Article
Closed access
SASristi Agrawal
Sristi Agrawal
ABAmol Chhatrapati Bisen
Amol Chhatrapati Bisen
ABArpon Biswas
Arpon Biswas
SSSachin Nashik Sanap
Sachin Nashik Sanap
SVSarvesh Kumar Verma
Sarvesh Kumar Verma
RBRabi Sankar Bhatta
Rabi Sankar Bhatta

23 August 2024 in Journal of Drug Delivery Science and Technology
Verified
Journal Article
Closed access
SKSamarth Kumar
Samarth Kumar
SSSachin N. Sanap
Sachin N. Sanap
MVMilan Vasoya
Milan Vasoya
MHMayank Handa
Mayank Handa
PPPrachi Pandey
Prachi Pandey
KSKrutika Sawant
Krutika Sawant

1 July 2023 in Therapeutic Delivery
Verified
Journal Article
Closed access
SSSachin Nashik Sanap
Sachin Nashik Sanap
ABAmol Chhatrapati Bisen
Amol Chhatrapati Bisen
SASristi Agrawal
Sristi Agrawal
AKAshwini Kedar
Ashwini Kedar
RBRabi Sankar Bhatta
Rabi Sankar Bhatta
Ophthalmic disease can cause permanent loss of vision and blindness. Easy-to-administer topical and systemic treatments are preferred for treating sight-threatening disorders. Typical ocular anatom... Graphical abstract

15 March 2024 in Journal of Drug Delivery Science and Technology
Verified
Journal Article
Closed access
SKSamarth Kumar
Samarth Kumar
SSSachin N. Sanap
Sachin N. Sanap
MVMilan Vasoya
Milan Vasoya
MHMayank Handa
Mayank Handa
PPPrachi Pandey
Prachi Pandey
KSKrutika K. Sawant
Krutika K. Sawant